Courtney S Young
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.6MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 13, 2026 | NIH | SBIR Phase II Further assessment of durability of a gene editing therapy for Duchenne muscular dystrophy | $978K | MYOGENE BIO LLC |
| May 12, 2025 | NIH | SBIR Phase II Further assessment of durability of a gene editing therapy for Duchenne muscular dystrophy | $1.3M | MYOGENE BIO LLC |
| Nov 23, 2021 | NIH | SBIR Phase II Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | $499K | MYOGENE BIO LLC |
| Sep 5, 2020 | NIH | SBIR Phase I Comparison of single versus dual vector delivery of AAV-SPY-DYS45-55 for Duchenne muscular dystrophy | $150K | MYOGENE BIO LLC |
| Jul 2, 2020 | NIH | SBIR Phase II Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | $494K | MYOGENE BIO LLC |
| Jul 30, 2019 | NIH | SBIR Phase II Pre-clinical development of SPY-DYS45-55, a CRISPR/Cas9 platform for Duchenne muscular dystrophy | $195K | MYOGENE BIO LLC |
Peer ranks
Federal funding#462
Awards as PI#315
Patents#273
Companies
- MYOGENE BIO LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.